Unique gene-silencing and structural properties of 2'-fluoro-modified siRNAs.

With little or no negative impact on the activity of small interfering RNAs (siRNAs), regardless of the number of modifications or the positions within the strand, the 2'-deoxy-2'-fluoro (2'-F) modification is unique. Furthermore, the 2'-F-modified siRNA (see crystal structure) was thermodynamically more stable and more nuclease-resistant than the parent siRNA, and produced no immunostimulatory response.

[1]  M. Sioud.  Recent advances in small interfering RNA sensing by the immune system. , 2010, New biotechnology.

[2]  Michael S. Goldberg,et al.  Development of lipidoid-siRNA formulations for systemic delivery to the liver. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[3]  I. MacRae,et al.  The RNA-induced Silencing Complex: A Versatile Gene-silencing Machine* , 2009, The Journal of Biological Chemistry.

[4]  R. Boisgard,et al.  Molecular imaging study on in vivo distribution and pharmacokinetics of modified small interfering RNAs (siRNAs). , 2008, Oligonucleotides.

[5]  W. Hagmann,et al.  The many roles for fluorine in medicinal chemistry. , 2008, Journal of medicinal chemistry.

[6]  Robert Langer,et al.  A combinatorial library of lipid-like materials for delivery of RNAi therapeutics , 2008, Nature Biotechnology.

[7]  Michael S. Goldberg,et al.  Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway , 2007, Nature.

[8]  Pirkko Muhonen,et al.  RNA Interference Tolerates 2′‐Fluoro Modifications at the Argonaute2 Cleavage Site , 2007, Chemistry & biodiversity.

[9]  E. Hovig,et al.  Gene expression analysis in blood cells in response to unmodified and 2'-modified siRNAs reveals TLR-dependent and independent effects. , 2007, Journal of molecular biology.

[10]  M. Manoharan,et al.  RNAi therapeutics: a potential new class of pharmaceutical drugs , 2006, Nature chemical biology.

[11]  N. Dean,et al.  Competition for RISC binding predicts in vitro potency of siRNA , 2006, Nucleic acids research.

[12]  M. Sioud.  Single‐stranded small interfering RNA are more immunostimulatory than their double‐stranded counterparts: A central role for 2′‐hydroxyl uridines in immune responses , 2006, European journal of immunology.

[13]  R. Griffey,et al.  Improving RNA interference in mammalian cells by 4'-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in combination with 2'-O-alkyl modifications. , 2006, Journal of medicinal chemistry.

[14]  Keith Bowman,et al.  Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs , 2005, Nature Biotechnology.

[15]  B. Polisky,et al.  Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication , 2005, Hepatology.

[16]  R. Griffey,et al.  Positional effect of chemical modifications on short interference RNA activity in mammalian cells. , 2005, Journal of Medicinal Chemistry.

[17]  D. Barford,et al.  Structural insights into mRNA recognition from a PIWI domain–siRNA guide complex , 2005, Nature.

[18]  S. Akira,et al.  Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7 , 2005, Nature Medicine.

[19]  R. Griffey,et al.  Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. , 2005, Journal of medicinal chemistry.

[20]  M. Manoharan.  RNA interference and chemically modified small interfering RNAs. , 2004, Current opinion in chemical biology.

[21]  P. Connett,et al.  Fluorine in medicine , 2004 .

[22]  J. Dunitz.  Organic Fluorine: Odd Man Out , 2004, Chembiochem : a European journal of chemical biology.

[23]  Anton P. McCaffrey,et al.  In vivo activity of nuclease-resistant siRNAs. , 2004, RNA.

[24]  T. Rana,et al.  siRNA function in RNAi: a chemical modification analysis. , 2003, RNA.

[25]  David R Corey,et al.  RNA interference in mammalian cells by chemically-modified RNA. , 2003, Biochemistry.

[26]  Thomas Tuschl,et al.  Sequence, chemical, and structural variation of small interfering RNAs and short hairpin RNAs and the effect on mammalian gene silencing. , 2003, Antisense & nucleic acid drug development.

[27]  E. Westhof,et al.  Hydrophobic Groups Stabilize the Hydration Shell of 2'-O-Methylated RNA Duplexes. , 2001, Angewandte Chemie.

[28]  M. Teplova,et al.  X-ray crystal structure of a locked nucleic acid (LNA) duplex composed of a palindromic 10-mer DNA strand containing one LNA thymine monomer , 2001 .

[29]  P. D. Cook,et al.  Crystal structure and improved antisense properties of 2'-O-(2-methoxyethyl)-RNA , 1999, Nature Structural Biology.

[30]  N. Usman,et al.  RNA hydration: a detailed look. , 1996, Biochemistry.

[31]  P. D. Cook,et al.  Uniformly modified 2'-deoxy-2'-fluoro phosphorothioate oligonucleotides as nuclease-resistant antisense compounds with high affinity and specificity for RNA targets. , 1993, Journal of medicinal chemistry.

[32]  F. Eckstein,et al.  Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes. , 1991, Science.

[33]  E. Rozners,et al.  Hydration of short DNA, RNA and 2'-OMe oligonucleotides determined by osmotic stressing. , 2004, Nucleic acids research.